Get the Stockscreener App
499.70
2.04%
-10.42
After Hours:
499.41
-0.29
-0.06%
Overview
News
Price History
Option Chain
Financials
Why MSFT Down?
Discussions
Forecast
Stock Split
Dividend History
Microsoft Corp stock is traded at $499.70, with a volume of 17.44M.
It is down -2.04% in the last 24 hours and up +1.40% over the past month.
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
See More
Previous Close:
$510.12
Open:
$510
24h Volume:
17.44M
Relative Volume:
0.48
Market Cap:
$3.71T
Revenue:
$318.27B
Net Income/Loss:
$125.22B
P/E Ratio:
29.76
EPS:
16.79
Net Cash Flow:
$72.92B
1W Performance:
-2.69%
1M Performance:
+1.40%
6M Performance:
+23.32%
1Y Performance:
-1.63%
1-Day Range:
$499.36
$511.00
1-Week Range:
$493.81
$515.65
52-Week Range:
$349.20
$553.72
Microsoft Corp Stock (MSFT) Company Profile
Name
Microsoft Corp
Sector
Industry
Phone
425-882-8080
Address
ONE MICROSOFT WAY, REDMOND, WA
Compare MSFT vs ORCL, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MSFT
Microsoft Corp
|
499.70 | 3.57T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
158.78 | 409.23B | 67.36B | 17.31B | -23.69B | 5.8248 |
PLTR
Palantir Technologies Inc
|
174.33 | 418.04B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
213.10 | 193.82B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
156.29 | 110.64B | 7.11B | 1.95B | 2.44B | 2.5883 |
Microsoft Corp Stock (MSFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-26 | Reiterated | Stifel | Hold |
| Sep-01-26 | Reiterated | BofA Securities | Buy |
| Aug-12-26 | Reiterated | Wells Fargo | Overweight |
| Jul-30-26 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-26 | Reiterated | UBS | Buy |
| Jul-21-26 | Resumed | Morgan Stanley | Overweight |
| Jul-20-26 | Initiated | CLSA | Outperform |
| Jul-10-26 | Reiterated | Argus | Buy |
| Jun-01-26 | Initiated | Citizens | Mkt Outperform |
| Apr-30-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-30-26 | Reiterated | Barclays | Overweight |
| Apr-30-26 | Reiterated | Bernstein | Outperform |
| Apr-30-26 | Reiterated | Citigroup | Buy |
| Apr-30-26 | Reiterated | Deutsche Bank | Buy |
| Apr-30-26 | Reiterated | Evercore ISI | Outperform |
| Apr-30-26 | Reiterated | Piper Sandler | Overweight |
| Apr-30-26 | Reiterated | Stifel | Hold |
| Apr-30-26 | Reiterated | The Benchmark Company | Buy |
| Apr-30-26 | Reiterated | Truist | Buy |
| Apr-30-26 | Reiterated | Wells Fargo | Overweight |
| Apr-28-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-26 | Reiterated | Citigroup | Buy |
| Apr-15-26 | Reiterated | Robert W. Baird | Outperform |
| Apr-14-26 | Reiterated | Mizuho | Outperform |
| Apr-14-26 | Reiterated | Piper Sandler | Overweight |
| Mar-25-26 | Reiterated | UBS | Buy |
| Mar-24-26 | Resumed | BofA Securities | Buy |
| Feb-09-26 | Downgrade | Melius | Buy → Hold |
| Feb-05-26 | Downgrade | Stifel | Buy → Hold |
| Feb-03-26 | Resumed | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-29-26 | Reiterated | Barclays | Overweight |
| Jan-29-26 | Reiterated | Bernstein | Outperform |
| Jan-29-26 | Reiterated | Citigroup | Buy |
| Jan-29-26 | Reiterated | Deutsche Bank | Buy |
| Jan-29-26 | Reiterated | Evercore ISI | Outperform |
| Jan-29-26 | Reiterated | Goldman | Buy |
| Jan-29-26 | Reiterated | JP Morgan | Overweight |
| Jan-29-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-29-26 | Reiterated | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-29-26 | Reiterated | Stifel | Buy |
| Jan-29-26 | Reiterated | Wedbush | Outperform |
| Jan-29-26 | Reiterated | Wells Fargo | Overweight |
| Jan-26-26 | Reiterated | Stifel | Buy |
| Jan-23-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Citigroup | Buy |
| Jan-21-26 | Reiterated | Mizuho | Outperform |
| Jan-12-26 | Reiterated | Barclays | Overweight |
| Jan-12-26 | Resumed | Goldman | Buy |
| Jan-08-26 | Reiterated | Wells Fargo | Overweight |
| Nov-18-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Nov-14-25 | Initiated | Robert W. Baird | Outperform |
| Oct-30-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-27-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-22-25 | Reiterated | Citigroup | Buy |
| Oct-17-25 | Reiterated | Mizuho | Outperform |
| Oct-06-25 | Reiterated | Wells Fargo | Overweight |
| Jul-31-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-31-25 | Reiterated | Barclays | Overweight |
| Jul-31-25 | Reiterated | Bernstein | Outperform |
| Jul-31-25 | Reiterated | BofA Securities | Buy |
| Jul-31-25 | Reiterated | Jefferies | Buy |
| Jul-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-31-25 | Reiterated | Mizuho | Outperform |
| Jul-31-25 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-25 | Reiterated | Oppenheimer | Outperform |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-31-25 | Reiterated | UBS | Buy |
| Jul-31-25 | Reiterated | Wedbush | Outperform |
| Jul-31-25 | Reiterated | Wells Fargo | Overweight |
| Jul-22-25 | Reiterated | Citigroup | Buy |
| Jul-16-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Jul-16-25 | Reiterated | Mizuho | Outperform |
| Jul-09-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-02-25 | Reiterated | DA Davidson | Buy |
| Jun-25-25 | Reiterated | Wedbush | Outperform |
| Jun-11-25 | Reiterated | Citigroup | Buy |
| May-01-25 | Reiterated | BMO Capital Markets | Outperform |
| May-01-25 | Reiterated | Barclays | Overweight |
| May-01-25 | Reiterated | Evercore ISI | Outperform |
| May-01-25 | Reiterated | Goldman | Buy |
| May-01-25 | Reiterated | JP Morgan | Overweight |
| May-01-25 | Reiterated | Mizuho | Outperform |
| May-01-25 | Reiterated | Piper Sandler | Overweight |
| May-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| May-01-25 | Reiterated | Raymond James | Outperform |
| May-01-25 | Reiterated | Scotiabank | Sector Outperform |
| May-01-25 | Reiterated | Stifel | Buy |
| May-01-25 | Reiterated | Wedbush | Outperform |
| Apr-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-16-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-14-25 | Reiterated | UBS | Buy |
| Apr-14-25 | Reiterated | Wells Fargo | Overweight |
| Mar-20-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-13-25 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-25 | Reiterated | Piper Sandler | Overweight |
| Oct-31-24 | Reiterated | BMO Capital Markets | Outperform |
| Oct-10-24 | Reiterated | Goldman | Buy |
| Oct-08-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-23-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-10-24 | Initiated | New Street | Buy |
| Jun-07-24 | Reiterated | Oppenheimer | Outperform |
| Apr-17-24 | Reiterated | Wells Fargo | Overweight |
| Apr-12-24 | Reiterated | BMO Capital Markets | Outperform |
| Apr-11-24 | Reiterated | Morgan Stanley | Overweight |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-18-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-13-23 | Initiated | Truist | Buy |
| Dec-05-23 | Initiated | China Renaissance | Buy |
| Oct-26-23 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-17-23 | Initiated | Loop Capital | Buy |
| Sep-25-23 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-15-23 | Initiated | HSBC Securities | Hold |
| Jul-24-23 | Reiterated | Goldman | Buy |
| Jul-24-23 | Reiterated | Raymond James | Outperform |
| Jul-21-23 | Reiterated | Goldman | Buy |
| Jul-19-23 | Reiterated | Barclays | Overweight |
| Jul-19-23 | Reiterated | BofA Securities | Buy |
| Jul-19-23 | Reiterated | Mizuho | Buy |
| Jul-19-23 | Reiterated | TD Cowen | Outperform |
| Jul-19-23 | Reiterated | Wells Fargo | Overweight |
| Jul-17-23 | Reiterated | Mizuho | Buy |
| Jul-14-23 | Upgrade | UBS | Neutral → Buy |
| Jul-13-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-26-23 | Reiterated | Goldman | Buy |
| Apr-26-23 | Reiterated | Guggenheim | Sell |
| Apr-26-23 | Reiterated | JP Morgan | Overweight |
| Apr-26-23 | Reiterated | Jefferies | Buy |
| Apr-26-23 | Upgrade | Macquarie | Neutral → Outperform |
| Apr-26-23 | Reiterated | Mizuho | Buy |
| Apr-26-23 | Reiterated | MoffettNathanson | Market Perform |
| Apr-26-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-26-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Reiterated | Piper Sandler | Overweight |
| Apr-26-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-26-23 | Reiterated | Raymond James | Outperform |
| Apr-26-23 | Reiterated | Rosenblatt | Buy |
| Apr-26-23 | Reiterated | Stifel | Buy |
| Apr-26-23 | Reiterated | TD Cowen | Outperform |
| Apr-26-23 | Reiterated | UBS | Neutral |
| Apr-26-23 | Reiterated | Wedbush | Outperform |
| Apr-26-23 | Reiterated | Wells Fargo | Overweight |
| Apr-26-23 | Reiterated | Wolfe Research | Outperform |
| Apr-24-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Apr-21-23 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Jan-25-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-17-23 | Downgrade | Guggenheim | Neutral → Sell |
| Jan-05-23 | Initiated | DA Davidson | Buy |
| Jan-04-23 | Downgrade | UBS | Buy → Neutral |
| Nov-02-22 | Initiated | Macquarie | Neutral |
| Oct-14-22 | Reiterated | Morgan Stanley | Overweight |
| Sep-30-22 | Resumed | Raymond James | Outperform |
| Sep-22-22 | Initiated | MoffettNathanson | Hold |
| Aug-12-22 | Initiated | Guggenheim | Neutral |
| Jul-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-22 | Reiterated | Citigroup | Buy |
| Jul-27-22 | Reiterated | Cowen | Outperform |
| Jul-27-22 | Reiterated | Deutsche Bank | Buy |
| Jul-27-22 | Reiterated | Stifel | Buy |
| Jul-27-22 | Reiterated | Wedbush | Outperform |
| Jul-26-22 | Initiated | Itau BBA | Outperform |
| Jul-19-22 | Reiterated | Citigroup | Buy |
| Jun-29-22 | Initiated | Redburn | Buy |
| Apr-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Apr-27-22 | Reiterated | Deutsche Bank | Buy |
| Apr-27-22 | Reiterated | Evercore ISI | In-line |
| Apr-27-22 | Reiterated | Stifel | Buy |
| Apr-27-22 | Reiterated | Wedbush | Outperform |
| Apr-27-22 | Reiterated | Wolfe Research | Outperform |
| Jan-26-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-26-22 | Reiterated | Citigroup | Buy |
| Jan-26-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-26-22 | Reiterated | Oppenheimer | Outperform |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-22-21 | Initiated | SMBC Nikko | Outperform |
| Nov-22-21 | Initiated | Wells Fargo | Overweight |
| Nov-16-21 | Resumed | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Buy |
| Oct-27-21 | Reiterated | Barclays | Overweight |
| Oct-27-21 | Reiterated | BofA Securities | Buy |
| Oct-27-21 | Reiterated | Cowen | Outperform |
| Oct-27-21 | Reiterated | Credit Suisse | Outperform |
| Oct-27-21 | Reiterated | Goldman | Buy |
| Oct-27-21 | Reiterated | Mizuho | Buy |
| Oct-27-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-27-21 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Reiterated | Stifel | Buy |
| Sep-17-21 | Resumed | Rosenblatt | Buy |
| Sep-14-21 | Reiterated | Morgan Stanley | Overweight |
| Aug-20-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Barclays | Overweight |
| Jul-28-21 | Reiterated | Bernstein | Outperform |
| Jul-28-21 | Reiterated | BofA Securities | Buy |
| Jul-28-21 | Reiterated | Citigroup | Buy |
| Jul-28-21 | Reiterated | Cowen | Outperform |
| Jul-28-21 | Reiterated | Credit Suisse | Outperform |
| Jul-28-21 | Reiterated | Griffin Securities | Buy |
| Jul-28-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-28-21 | Reiterated | Piper Sandler | Overweight |
| Jul-28-21 | Resumed | RBC Capital Mkts | Outperform |
| Jul-28-21 | Reiterated | Rosenblatt | Buy |
| Jul-28-21 | Reiterated | Stifel | Buy |
| Jul-28-21 | Reiterated | Wolfe Research | Outperform |
| Jul-22-21 | Reiterated | BofA Securities | Buy |
| Jul-22-21 | Reiterated | Citigroup | Buy |
| Jul-22-21 | Reiterated | Cowen | Outperform |
| Jul-22-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jun-23-21 | Reiterated | Wedbush | Outperform |
| May-13-21 | Initiated | Rosenblatt | Buy |
| Apr-23-21 | Initiated | Wolfe Research | Outperform |
| Apr-12-21 | Reiterated | BMO Capital Markets | Outperform |
| Apr-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-03-21 | Resumed | Citigroup | Buy |
| Jan-26-21 | Resumed | Raymond James | Strong Buy |
| Jan-22-21 | Initiated | Goldman | Buy |
| Dec-21-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Buy |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-14-20 | Resumed | UBS | Buy |
| Jul-23-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-20-20 | Reiterated | Stifel | Buy |
| Jul-15-20 | Reiterated | BMO Capital Markets | Outperform |
| Jul-09-20 | Reiterated | Wedbush | Outperform |
| Jun-24-20 | Reiterated | Argus | Buy |
| Jun-02-20 | Reiterated | Wells Fargo | Overweight |
| May-27-20 | Initiated | Summit Insights | Buy |
| Apr-30-20 | Reiterated | Griffin Securities | Buy |
| Jan-30-20 | Reiterated | Oppenheimer | Outperform |
| Jan-30-20 | Reiterated | Piper Sandler | Overweight |
| Jan-30-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-30-20 | Reiterated | Raymond James | Strong Buy |
| Jan-30-20 | Reiterated | Stifel | Buy |
| Jan-30-20 | Reiterated | Wedbush | Outperform |
| Jan-30-20 | Reiterated | Wells Fargo | Overweight |
View All
Microsoft Corp Stock (MSFT) Latest News
Microsoft Has a $1,000 Problem With Its Next Xbox - tradingview.com
MSFT Has Gone Nowhere in 2026—Azure Says That's a Mistake - tradingview.com
Microsoft stock gains after strong July earnings and AI-driven Azure growth - AD HOC NEWS
Why Microsoft (MSFT) is a Top Stock for the Long-Term - Zacks Investment Research
Exclusive: Coursera, Microsoft and Steve Hanke on the Future of Jobs — AI Could Be a ‘Net Job Creator’ - Benzinga
Industry Comparison: Evaluating Microsoft Against Competitors In Software Industry - Benzinga
Microsoft stock heads into the open after a 1.6% drop - AD HOC NEWS
Microsoft Corporation - Britannica
Seattle Times, Newsday sue OpenAI, Microsoft, alleging copyright infringement - Yahoo! Finance Canada
Seattle Times sues Microsoft and OpenAI, alleging they trained their AI on its journalism - GeekWire
Microsoft Says Feeding Books And News To AI Is Fair Use - Law360
Microsoft Corp. (MSFT) Stock Price, Quote & News - techi.com
Microsoft Stock Gets Jaw-Dropping Price Target Hike From Stifel - GuruFocus
Microsoft CEO Nadella Sells $43 Million in Stock Under Pre-Set Plan, First Sale of 2026 - finance.biggo.com
Microsoft Stock: Why Satya Nadella's $44 Million Sale May Not Spook Investors - Benzinga
Microsoft, OpenAI Urge Court to Find AI Training Is Fair Use (1) - news.bloomberglaw.com
Microsoft to bounce mail from outdated Exchange servers - The Register
Microsoft's Cloud Gaming Push Just Picked Up a New Limit - tradingview.com
Assessing Microsoft's Performance Against Competitors In Software Industry - Benzinga
Stifel Adjusts Price Target on Microsoft to $530 From $450, Keeps Hold Rating - marketscreener.com
Microsoft (MSFT) Restructures Financial Reporting to Highlight A - GuruFocus
Microsoft Corp (MSFT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VistaShares Target 15 S&P 100 Distribution ETF's Microsoft Corp(MSFT) Holding History - GuruFocus
AI Outage Affects Major Platforms, Microsoft (MSFT) Azure Implicated - GuruFocus
Microsoft Finally Reveals Azure's $29.4 Billion Core - Yahoo Finance
Amazon vs. Microsoft: 1 Key Metric Identifies the Superior Artificial Intelligence (AI) Cloud Stock - The Motley Fool
Microsoft challenges data centre costs after pledging to protect ratepayers - Financial Times
Sony, Microsoft Ask Courts to Toss PS5, Xbox Tariff Refund Class Actions - finance.biggo.com
What's Going On With Microsoft Stock Thursday?Microsoft (NASDAQ:MSFT) - Benzinga
KeyBanc reiterates Microsoft stock Overweight on cleaner Azure disclosure - Investing.com
Microsoft Corp Stock (MSFT) Moved Up by 3.12% on Sep 3: Drivers Behind the Movement - TradingKey
Microsoft Prepares to Disclose Standalone Azure Cloud Revenues in Major Reporting Overhaul - TIKR.com
Moonshot AI Files For IPO At $50B ValuationMicrosoft (NASDAQ:MSFT) - Benzinga
Microsoft Is Rewiring Its Business for the AI Era - Yahoo Finance
Inquiry Into Microsoft's Competitor Dynamics In Software Industry - Benzinga
Microsoft To Disclose Azure Sales After Investor Gripes - NDTV Profit
DOJ Backs OpenAI, Microsoft Fair Use Defense In NYT IP Case - Law360
Microsoft (MSFT) Announces Major Segment Restructuring Ahead of Fiscal Year 2027 - GuruFocus
Microsoft offers first quarter outlook under new segment structure - Investing.com
Microsoft Discloses Exact Azure Sales Figures For The First Time Following Longstanding Investor Demand - Yahoo Finance
Satya Nadella sells Microsoft (NASDAQ: MSFT) stock near $500 under preset plan - Stock Titan
Microsoft To Transition To Two Reporting Segments In 2027, Affirms Q1 Revenue Outlook - marketscreener.com
Microsoft to Change Reporting Structure to Reflect Effects of AI - marketscreener.com
Microsoft to detail quarterly Azure sales in sweeping reportable segment revamp - Investing.com
Microsoft to Disclose Azure Sales After Investor Gripes - Bloomberg.com
Microsoft updates FY27 reporting to two segments, restates FY26 results and provides FY27 Q1 outlook - TradingView
Over $50B in FY27 Q1 capex as Microsoft (NASDAQ: MSFT) reorganizes around AI - Stock Titan
Napster Shifts Course to Penny-a-Minute AI Agents Via Microsoft - Bloomberg.com
A Microsoft Bull Just Closed $36 Million in Call Spreads That Do Not Expire Until 2027 - 24/7 Wall St.
Microsoft Stock Holds $499 as Azure Growth Supports the Next MSFT Breakout - TradingKey
What's Going On With Microsoft Stock Wednesday?Microsoft (NASDAQ:MSFT) - benzinga.com
Microsoft Corp Stock (MSFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.08%
4.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):